In a study of neuroblastoma patients undergoing chemotherapy, CGREF1 has been identified as a novel somatic mutation during chemotherapy that is involved in mediating nerve cell growth and may be associated with chemotherapy resistance and poor prognosis in neuroblastoma patients(Duan et al. 2018). The gene discussed is CGREF1; the disease is neuroblastoma.